Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021003428 - IMMUNOTHERAPY TARGETING CELL SURFACE MARKER CD72 FOR THE TREATMENT OF B-CELL MALIGNANCIES

Publication Number WO/2021/003428
Publication Date 07.01.2021
International Application No. PCT/US2020/040749
International Filing Date 02.07.2020
IPC
C07K 16/28 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
A61K 39/395 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61K 38/17 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
Applicants
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US]/[US]
Inventors
  • NIX, Matthew
  • WIITA, Arun
Agents
  • LOCKYER, Jean M.
  • HINSCH, Matthew E.
  • BORING, Landin F.
  • FERNANDEZ, Lizette M.
  • FOLLETTE, Peter J.
  • ROBERGE, Christopher M.
  • YAO, Zhengzheng
Priority Data
62/870,46303.07.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) IMMUNOTHERAPY TARGETING CELL SURFACE MARKER CD72 FOR THE TREATMENT OF B-CELL MALIGNANCIES
(FR) IMMUNOTHÉRAPIE CIBLANT LE MARQUEUR DE SURFACE CELLULAIRE CD72 POUR LE TRAITEMENT DE MALIGNITÉS DES LYMPHOCYTES B
Abstract
(EN)
Provided herein are anti-CD72 nanobodies and methods of using such nanobodies for diagnostic and therapeutic purposes.
(FR)
La présente invention concerne des nanocorps anti-CD72 et des méthodes d'utilisation de tels nanotubes à des fins de diagnostic et de thérapie.
Latest bibliographic data on file with the International Bureau